HPV Update: Vaccination, Screening, and Associated Disease.

Area of Science:

• Oncology
• Virology
• Public Health

Background:

• Human papillomavirus (HPV) is the primary cause of cervical cancer and is linked to other genital cancers.
• HPV vaccination is a safe and effective primary prevention strategy.
• Screening methods for HPV are continuously advancing.

Purpose of the Study:

• To review new evidence on the efficacy of the 9-valent HPV (9vHPV) vaccine.
• To discuss the role of primary high-risk HPV testing in cervical cancer screening.
• To evaluate urinary HPV testing and anal HPV screening guidelines.

Main Methods:

• Literature review of recent studies on 9vHPV vaccine efficacy.
• Analysis of current cervical cancer screening guidelines incorporating HPV testing.
• Review of research on the utility of urinary HPV detection.
• Examination of guidelines for anal HPV screening.

Main Results:

• The 9vHPV vaccine provides broad protection against oncogenic HPV strains.
• Primary high-risk HPV testing is a key component of evolving cervical cancer screening strategies.
• Urinary HPV testing shows potential for clinical application.
• Updated guidelines address anal HPV screening.

Conclusions:

• The 9vHPV vaccine represents a significant advancement in primary prevention of HPV-related cancers.
• High-risk HPV testing is integral to modern cervical cancer screening protocols.
• Further evaluation of urinary HPV testing and adherence to anal HPV screening guidelines are important for comprehensive HPV management.